GRISTWOOD; Robert William
Patent Applications and Registrations
Patent applications and USPTO patent grants for GRISTWOOD; Robert William.The latest application filed is for "use of amisulpride as an anti-emetic".
Company Profile
5.19.25
- GRISTWOOD; Robert William - Cambridge GB
- Gristwood; Robert William - Cambridgeshire GB
Patent Activity
| Patent | Date |
|---|---|
| Use Of Amisulpride As An Anti-emetic App 20220296570 - GILBERT; Julian Clive ; et al. | 2022-09-22 |
| Rescue treatment of post operative nausea and vomiting Grant 11,357,753 - Gilbert , et al. June 14, 2 | 2022-06-14 |
| Use Of Amisulpride As An Anti-emetic App 20210228543 - GILBERT; Julian Clive ; et al. | 2021-07-29 |
| Use Of Amisulpride As An Anti-emetic App 20200093792 - GILBERT; Julian Clive ; et al. | 2020-03-26 |
| Rescue Treatment Of Post Operative Nausea And Vomiting App 20200038369 - GILBERT; Julian Clive ; et al. | 2020-02-06 |
| Use of amisulpride as an anti-emetic Grant 10,525,033 - Gilbert , et al. J | 2020-01-07 |
| Therapy Of Post-operative Emesis With Amisulpride App 20190262310 - GILBERT; Julian Clive ; et al. | 2019-08-29 |
| Combinations of amisulpride and another anti-emetic for treating nausea and vomiting Grant 10,322,106 - Gilbert , et al. | 2019-06-18 |
| Use Of Amisulpride As An Anti-emetic App 20180353473 - GILBERT; Julian Clive ; et al. | 2018-12-13 |
| Use of bethanechol for treatment of xerostomia Grant 10,137,084 - Cooper , et al. November 27, 2 | 2018-11-27 |
| Use of amisulpride as an anti-emetic Grant 10,085,970 - Gilbert , et al. October 2, 2 | 2018-10-02 |
| Combinations Of Amisulpride And Another Anti-emetic For Treating Nausea And Vomiting App 20180071249 - GILBERT; Julian Clive ; et al. | 2018-03-15 |
| Use Of Amisulpride As An Anti-emetic App 20180042896 - Gilbert; Julian Clive ; et al. | 2018-02-15 |
| Use of amisulpride as an anti-emetic Grant 9,889,118 - Gilbert , et al. February 13, 2 | 2018-02-13 |
| Use Of Amisulpride As An Anti-emetic App 20170087128 - Gilbert; Julian Clive ; et al. | 2017-03-30 |
| Use of amisulpride as an anti-emetic Grant 9,545,426 - Gilbert , et al. January 17, 2 | 2017-01-17 |
| Use Of Bethanechol For Treatment Of Xerostomia App 20160287512 - Cooper; Nicola ; et al. | 2016-10-06 |
| Use Of Bethanechol For Treatment Of Xerostomia App 20150366794 - Cooper; Nicola ; et al. | 2015-12-24 |
| Use of Amisulpride as an Anti-Emetic App 20150335616 - Gilbert; Julian Clive ; et al. | 2015-11-26 |
| Use of bethanechol for treatment of xerostomia Grant 9,149,454 - Cooper , et al. October 6, 2 | 2015-10-06 |
| Use of amisulpride as an anti-emetic Grant 9,119,836 - Gilbert , et al. September 1, 2 | 2015-09-01 |
| Use of Amisulpride as an Anti-Emetic App 20140147517 - Gilbert; Julian Clive ; et al. | 2014-05-29 |
| Use of amisulpride as an anti-emetic Grant 8,686,019 - Gilbert , et al. April 1, 2 | 2014-04-01 |
| Drug combination and its use in the treatment of muscle loss Grant 8,653,052 - Gilbert , et al. February 18, 2 | 2014-02-18 |
| Use of Amisulpride as an Anti-Emetic App 20130022689 - Gilbert; Julian Clive ; et al. | 2013-01-24 |
| Use of Bethaneciol for Treatment of Xerostomia App 20120232137 - Cooper; Nicola ; et al. | 2012-09-13 |
| Drug Combination and Its Use in the Treatment of Muscle Loss App 20100130456 - Gilbert; Julian Clive ; et al. | 2010-05-27 |
| New Therapeutic Use Of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine App 20090215791 - Bardsley; Hazel Judith ; et al. | 2009-08-27 |
| 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder Grant 7,470,690 - Cavalla , et al. December 30, 2 | 2008-12-30 |
| Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-pyrimidin- e for treating of urinary incontinence Grant 7,220,748 - Cavalla , et al. May 22, 2 | 2007-05-22 |
| New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno [2,3-d] pyrimidine App 20060167005 - Cavalla; David ; et al. | 2006-07-27 |
| Topical formulation and use of buspirone App 20060088556 - Cavalla; David ; et al. | 2006-04-27 |
| Use of ppar activators for the treatment of pulmonary fibrosis App 20060013775 - Gristwood; Robert William ; et al. | 2006-01-19 |
| 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d)pyrimidine in the treatment of functional bowel disorder App 20050239792 - Cavalla, David ; et al. | 2005-10-27 |
| Use of 4-(2-flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d)-pyrimidin- e for treating of urinary incontinence App 20050222162 - Cavalla, David ; et al. | 2005-10-06 |
| Arylazo-substituted imidazole for the treatment of stress urinary incontinence App 20040242547 - Gristwood, Robert William ; et al. | 2004-12-02 |
| New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno- [2,3-D]pyrimidine App 20040048874 - Bardsley, Hazel Judith ; et al. | 2004-03-11 |
| Analgesic agent and its use Grant 6,103,741 - Bardsley , et al. August 15, 2 | 2000-08-15 |
| Use of levobupivacaine as an anesthetic agent Grant 5,849,763 - Bardsley , et al. December 15, 1 | 1998-12-15 |
| Use of levobupivacaine in a patient having depressed myocardial contractility Grant 5,708,011 - Bardsley , et al. January 13, 1 | 1998-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 